[HTML][HTML] Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant …
…, E Laas, D De Croze, L Topciu, GT Lam, C Evrevin… - PloS one, 2020 - journals.plos.org
Introduction The Residual Cancer Burden (RCB) quantifies residual disease after neoadjuvant
chemotherapy (NAC). Its predictive value has not been validated on large cohorts with …
chemotherapy (NAC). Its predictive value has not been validated on large cohorts with …
[HTML][HTML] Impact of BRCA Mutation Status on Tumor Infiltrating Lymphocytes (TILs), Response to Treatment, and Prognosis in Breast Cancer Patients Treated with …
B Grandal, C Evrevin, E Laas, I Jardin, S Rozette… - Cancers, 2020 - mdpi.com
Simple Summary High lymphocytic infiltration (TILs) seem to reflect favorable host antitumor
immune responses. In breast cancer, the variation of TILs before and after neoadjuvant …
immune responses. In breast cancer, the variation of TILs before and after neoadjuvant …
Impact of hormonal contraception on endometrial histology in patients with Lynch syndrome, a retrospective pilot study
M Mawet, C Evrevin, A Dardenne, F Kridelka… - Familial Cancer, 2024 - Springer
Hormonal contraception (HC) is a well-recognized protection against endometrial cancer (EC)
in the general population. It has not been established if this is also applicable to women …
in the general population. It has not been established if this is also applicable to women …
[HTML][HTML] Prédispositions génétiques au cancer de l'endomètre
C EVREVIN - gyneco-online.com
Le cancer de l’endomètre est devenu le cancer gynécologique le plus fréquent dans les
pays industrialisés, avec une incidence continuellement à la hausse compte tenu de l’épidémie …
pays industrialisés, avec une incidence continuellement à la hausse compte tenu de l’épidémie …
[HTML][HTML] Contraception in breast cancer survivors from the FEERIC case-control study (performed on behalf of the Seintinelles research network)
…, F Coussy, I Ray-Coquard, C Garin, C Evrevin… - The Breast, 2023 - Elsevier
Objective To compare the prevalence of contraception in breast cancer (BC) patients at risk
of unintentional pregnancy (ie not currently pregnant or trying to get pregnant) and matched …
of unintentional pregnancy (ie not currently pregnant or trying to get pregnant) and matched …
Abstract PS13-10: Impact of BRCA mutation status on immune infiltration, chemosensitivity, and prognosis of breast cancer patients treated with neoadjuvant …
Context: The majority of BRCA mutation carriers diagnosed with breast cancer (BC) are
treated with chemotherapy. The effectiveness of standard neoadjuvant chemotherapy (NAC) in …
treated with chemotherapy. The effectiveness of standard neoadjuvant chemotherapy (NAC) in …
Abstract P2-16-36: Survival benefit of neoadjuvant chemotherapy versus adjuvant chemotherapy in HER2-positive early breast cancer: A propensity score-weighted …
…, B Grandal, E De Guillebon, S Rozette, C Evrevin… - Cancer Research, 2020 - AACR
INTRODUCTION: Neoadjuvant chemotherapy (NAC) is increasingly being used for locally
advanced breast cancers (BCs) or aggressive BC tumors. However, no survival benefit of the …
advanced breast cancers (BCs) or aggressive BC tumors. However, no survival benefit of the …
Abstract P2-16-35: Impact of neoadjuvant chemotherapy on survival in luminal B tumours: A propensity score weighted analysis
…, A Bellesoeur, E De Guillebon, S Rozette, C Evrevin… - Cancer Research, 2020 - AACR
BACKGROUND: Although no survival benefit has been demonstrated by treating early
breast cancer (BC) with neoadjuvant chemotherapy (NAC), it is now widely accepted as first …
breast cancer (BC) with neoadjuvant chemotherapy (NAC), it is now widely accepted as first …
[CITATION][C] Impact du statut BRCA sur l'infiltration tumorale lymphocytaire, la réponse à la chimiothérapie néoadjuvante et données de survie dans le cancer du sein
C Evrevin - 2020
